Analyst Ratings for West Pharmaceutical (WST)
WST Rating Summary
WST Price Target Summary
- Highest: $447.00 (BNP Paribas Exane)
- Lowest: $311.00 (Rothschild Redburn)
- Average: $379.30
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$379.30 (+12%)
* Over Last 12-Mos
Rating Score: 8.9 / 10
Percentile Rank: 88%
Avg. $ Target:
$379.30 (+12%)
* Over Last 12-Mos
Rating Score: 8.9 / 10
Percentile Rank: 88%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/13/2026 | BNP Paribas Exane | N/A | New Coverage | Outperform (N/A) |
447.00 (N/A) |
353.71 (338.65) |
-4.26% | Details |
| 6/9/2026 | Barclays | Luke Sergott | Upgrade | Overweight (Equalweight) |
400.00 (310.00) |
319.75 (338.65) |
5.91% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
